NEW
MyHep ALL

MyHep ALL Overdosage

sofosbuvir + velpatasvir

Manufacturer:

Mylan Healthcare

Distributor:

Antah Pharma
Full Prescribing Info
Overdosage
The highest documented doses of sofosbuvir and velpatasvir were a single dose of 1,200 mg and a single dose of 500 mg, respectively. In these healthy volunteer studies, there were no untoward effects observed at these dose levels, and adverse events were similar in frequency and severity to those reported in the placebo groups. The effects of higher doses/exposures are not known.
No specific antidote is available for overdose with Sofosbuvir and Velpatasvir tablet. If overdose occurs the patient must be monitored for evidence of toxicity. Treatment of overdose with Sofosbuvir and Velpatasvir tablet consists of general supportive measures including monitoring of vital signs, as well as observation of the clinical status of the patient. Haemodialysis can efficiently remove the predominant circulating metabolite of sofosbuvir, GS-331007, with an extraction ratio of 53%. Haemodialysis is unlikely to result in significant removal of velpatasvir, since velpatasvir is highly bound to plasma protein.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in